What's driving Dermal Filler Market Growth? Top Players: Allergan, Merz, Galderma, Cynosure, Inc., Sinclair Pharma plc, Cytophil, Inc., Huons, Co

Rising awareness and acceptance regarding several cosmetic procedures in developed and developing regions coupled with increasing disposable income will impel dermal filler market size. Demand for dermal filler injections dramatically increased during recent years among high income Saudi Arabian women. Moreover, rising awareness about superior benefits coupled with minimal pain involved with the procedure will drive global dermal filler market growth.

With increasing preference for minimally invasive and non-invasive procedures, dermal filler business will witness considerable increase in its revenue size. As per data based on a clinical center in the U.S., the demand for surgical facelifts declined as several surgeons started offering non-invasive facelifts, called mini-lifts using dermal fillers in the country. Additionally, these soft tissue fillers offer quick, affordable and durable treatment that should offer lucrative dermal filler market growth potential over the coming years.

Dermal Filler Market size is set to exceed USD 8.5 billion by 2024; according to a new research report by Global Market Insights.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3032
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
1. Allergan
2. Merz
3. Galderma
4. Syneron Medical
5. Cynosure, Inc.
6. Sinclair Pharma plc
7. Suneva Medical
8. Cytophil, Inc.
9. BIOHA Laboratories
10. Shanghai Bioha Technology Co., Ltd.
11. Prollenium Medical Technologies, Inc.
12. Teoxane S.A.
13. Croma Pharma GmbH
14. Huons, Co
15. Hangzhou Gallop Biological Products Co., Ltd

Calcium hydroxylapatite (CaHA) dermal filler material type segment contributed to 8.1% market share in 2017. CaHA is biodegradable filler that can be tested for any facial correction treatment for a short duration. Additionally, CaHA dermal fillers are rarely associated with post procedure complications that should support its rapid adoption in forecast timeframe.

Facial line correction application segment accounted for largest market size of USD 2,511.1 in 2017 and the segment is forecasted to dominate the market throughout the estimation period. Expanding geriatric population across the globe seeking anti-aging and wrinkle treatment will be high impact rendering factor for segmental growth. Accelerating demand for numerous beauty enhancement procedures will further support facial line correction segment growth till 2024.

Medical spas, rejuvenation centers & surgeons office end-use segment will witness momentous growth at 6.6% CAGR over the projection timeframe. Remarkably growing demand for facial fillers at medical spas can be attributed to availability of specialized and affordable treatment options. Based on data from American Med Spa Association, facial filler constituted among the top three revenue-generating treatments in the U.S. Such factors will highly impact segmental growth.

Italy dermal filler market accounted for the highest market share of 24.2% of Europe dermal filler market in 2017. High revenue share can be attributable to growing adoption of non-invasive cosmetic procedures across Italy. According to The International Society of Plastic Surgery (ISAPS), around 266,100 injectable procedures were performed in Italy in 2017. In addition, presence of sufficient number of plastic surgeons in the country offer momentous Italy dermal filler industry growth in the forthcoming period.

Australia dermal filler market will foresee remarkable progress at 8.2% CAGR throughout the forecast timeframe. Increasing spending on non-invasive beauty treatments especially among baby boomers will highly impact dermal filler business growth. As per data from The Cosmetic Physicians Society of Australasia, demand for dermal fillers significantly increased during 2014 and is estimated to rise over the coming years. Thus, growing elderly population and presence of established players such as Allergan should augment Australia dermal filler market growth over the upcoming period.

Some of the notable players operating in dermal filler market are Allergan PLC, Merz Aesthetics, Galderma Laboratories (Nestle) and Bioform Medical, Inc. Major market players are concentrating on R&D to develop and introduce superlative and improved product to capture significant market share and gain competitive edge. For instance, in December 2016, Galderma Laboratories received approval from the US FDA for two next-generation hyaluronic acid dermal fillers Restylane Defyne and Restylane Refyne.

Browse Report Summary @ https://www.gminsights.com/industry-analysis/dermal-filler-market

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: www.gminsights.com/

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.